scholarly journals Adjuvant chemotherapy combination of vinblastine, actinomycin D, bleomycin, and chlorambucil following retroperitoneal lymph node dissection for stage II testis tumor

Cancer ◽  
1981 ◽  
Vol 47 (5) ◽  
pp. 840-844 ◽  
Author(s):  
Davor Vugrin ◽  
Willet F. Whitmore ◽  
Esteban Cvitkovic ◽  
Harry Grabstald ◽  
Pramod Sogani ◽  
...  
Keyword(s):  
Lymph Node ◽  
Adjuvant Chemotherapy ◽  
Lymph Node Dissection ◽  
Actinomycin D ◽  
Stage Ii ◽  
Retroperitoneal Lymph Node Dissection ◽  
Node Dissection ◽  
Retroperitoneal Lymph Node ◽  
Testis Tumor

Stage II nonseminomatous testicular cancer: a 10-year experience.

1983 ◽  
Vol 1 (3) ◽  
pp. 171-178 ◽  
Author(s):  
N J Vogelzang ◽  
E E Fraley ◽  
P H Lange ◽  
J Torkelson ◽  
S Levitt ◽  
...  
Keyword(s):  
Lymph Node ◽  
Adjuvant Chemotherapy ◽  
Germ Cell ◽  
Lymph Node Dissection ◽  
Stage Ii ◽  
Retroperitoneal Lymph Node Dissection ◽  
University Of Minnesota ◽  
Node Dissection ◽  
Retroperitoneal Lymph Node ◽  
Testicular Carcinoma

Between 1970 and 1980, 82 patients with pathologic stage II nonseminomatous germ cell testicular carcinoma were treated at the University of Minnesota. Of the 30 patients treated with a retroperitoneal lymph node dissection, 22 (77%) relapsed. Of the 18 patients treated with retroperitoneal lymph node dissection and adjuvant radiotherapy, 12 (63%) relapsed. Sixteen patients received adjuvant chemotherapy before 1976, and 14 (87.5%) relapsed. After 1976, 18 patients received adjuvant chemotherapy (11 with cisplatin) and 2 (11%) have relapsed. No patient treated with cisplatin-based adjuvant chemotherapy has relapsed. The toxicity has been modest. Cisplatin-based chemotherapy is an effective and a safe adjuvant therapy for stage II nonseminomatous germ cell testicular carcinoma.

1003: Primary Laparoscopic Retroperitoneal Lymph-Node Dissection for Clinical Stage I Nonseminomatous Germ-Cell Testis Tumor

2007 ◽  
Vol 177 (4S) ◽  
pp. 331-331 ◽  
Author(s):  
Octavio Castillo ◽  
Jose M. Campero ◽  
Rafael Sánchez-Salas ◽  
Fernando P. Secin ◽  
Gonzalo Vitagliano ◽  
...  
Keyword(s):  
Lymph Node ◽  
Germ Cell ◽  
Lymph Node Dissection ◽  
Clinical Stage ◽  
Stage I ◽  
Retroperitoneal Lymph Node Dissection ◽  
Node Dissection ◽  
Retroperitoneal Lymph Node ◽  
Testis Tumor

scholarly journals Does negative retroperitoneal CT in adolescents with paratesticular rhabdomyosarcoma preclude the need of retroperitoneal lymph node dissection?

2011 ◽  
Vol 9 (4) ◽  
pp. 527-529 ◽  
Author(s):  
Eulalio Damazio ◽  
Eliana Caran ◽  
Valdemar Ortiz ◽  
Antonio Macedo Junior
Keyword(s):  
Lymph Node ◽  
Adjuvant Chemotherapy ◽  
Lymph Node Dissection ◽  
Metastatic Disease ◽  
Disease Patient ◽  
Group Iv ◽  
Retroperitoneal Lymph Node Dissection ◽  
Study Group ◽  
Node Dissection ◽  
Retroperitoneal Lymph Node

ABSTRACT We report on a 16-year-old male with paratesticular rhabdomyosarcoma who underwent retroperitoneal lymph node dissection due to a stage I tumor (normal retroperitoneal computed tomoghaphy). The surgical finding was three enlarged nodes, positive for metastatic disease. Patient was referred to adjuvant chemotherapy. This case suggests that the Intergroup Rhabdomyosarcoma Study Group IV protocol is subject to questions regarding adolescents with paratesticular rhabdomyosarcoma, and that negative retroperitoneal CT does not preclude the need of lymph node dissection.

Sign in / Sign up

Export Citation Format

Share Document